Jinqi Li, Yan Zang, Haihui Gu, Baohua Qian. Molecular hydrogen as a new selective anti-oxidation therapeutic medical gas for clinical research[J]. Blood&Genomics, 2018, 2(1): 21-26. DOI: 10.46701/APJBG.2018012018005
Citation: Jinqi Li, Yan Zang, Haihui Gu, Baohua Qian. Molecular hydrogen as a new selective anti-oxidation therapeutic medical gas for clinical research[J]. Blood&Genomics, 2018, 2(1): 21-26. DOI: 10.46701/APJBG.2018012018005

Molecular hydrogen as a new selective anti-oxidation therapeutic medical gas for clinical research

More Information
  • Available Online: 2021-06-29
  • Hydrogen (H2) is a colorless, odorless gas that can act as a reducing agent under certain circumstances. Previously considered physiologically an inert and nonfunctional molecule in mammalian cells, H2 largely went ignored until Nature Medicine revealed the antioxidant and cytoprotective effects of hydrogen gas in a focal stroke model. Reactive oxygen species (ROS)is generated inside the body throughout our daily lives as a by-product of the energy metabolism by oxidative phosphorylation, which can cause biofilm system damage and intracellular oxidative phosphorylation disorders. H2 reacts with highly reactive oxidants such as hydroxyl radical (·OH) and peroxynitrite (ONOO-) inside cells to improve ischemia reperfusion injury. In addition, hydrogen is a potent antiapoptotic and anti-inflammatory agent and can be used for potential medical applications in cells, tissues and organs. As a new antioxidant, hydrogen has the advantages of non-toxicity, easy diffusion and selective neutralization. This review makes a case for supporting hydrogen as a new antioxidant medicine for clinical applications. We also hope to provide a reference for the further study of hydrogen to preserve blood cells in transfusion medicine.
  • Related Articles

    [1]Lu Chen, Yawen Zhuang, Jingjing Zhang, Yi Zhu. Research Progress in Interactions between Bile Acids, Gastrointestinal Microbes and GPBAR1 in Pancreatic Cancer[J]. Blood&Genomics, 2024, 8(2): 10003. DOI: 10.70322/BG20240210003
    [2]Ying Yu, Hongjun Gao, Fangfang Chen, Zhejiong Wang. Molecular Basis and Clinical Research Progress of the Vel Blood Group System[J]. Blood&Genomics, 2024, 8(2): 10002. DOI: 10.70322/BG20240210002
    [3]Lilan Zhang, Sihan Lai, Ying He, Shan Zhang, Yan Deng, Ying Han, Guangcui He, Hai Yi. Camrelizumab for Preemptive Treatment of Molecular Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Core-Binding Factor Acute Myeloid Leukemia: Two Case Reports[J]. Blood&Genomics, 2024, 8(1): 10005. DOI: 10.70322/BG20240110005
    [4]Lei Shao, Jinhua Wang, Shaowen Zhu, Hong Lin. Iron stores in Chinese eligible male plateletpheresis donors[J]. Blood&Genomics, 2019, 3(2): 109-114. DOI: 10.46701/APJBG.2019022019115
    [5]Tiejun Song, Jun Huang, Ying Zhang, Yingjian Wang, Yetao Han, Mengsi Hu, Zhiwei Liu. One case of platelet donor selection for a platelet transfusion refractory patient of the ethnic minority descent[J]. Blood&Genomics, 2018, 2(2): 129-131. DOI: 10.46701/APJBG.2018022018114
    [6]Zhiyuan Xu, Haochun Chang, Xiaojie Zhu, Chen Cao, Tianhong Miao, Jiwu Gong, Yu-Shiang Lin. Serological and molecular analysis of anti-Tja: Case report[J]. Blood&Genomics, 2018, 2(2): 125-128. DOI: 10.46701/APJBG.2018022018108
    [7]TingtingYang, Qi Tang. The improved method in agarose gel electrophoresis of nucleic acid[J]. Blood&Genomics, 2018, 2(1): 67-70. DOI: 10.46701/APJBG.2018012018002
    [8]Yanjun Jia, Wei Li, Lijun Wang, Na Liu, Dongmei Wang, Dongmei Li, Yuanyuan Jing, Jie Wang, Zhongmei Wang, Xiaoyan Shan. Allele and haplotype frequencies of human leukocyte antigen-A, -B, -C,-DRB1, and -DQB1 in Chinese patients with hematological diseases[J]. Blood&Genomics, 2018, 2(1): 27-37. DOI: 10.46701/APJBG.2018012017064
    [9]Wen Wu, Yecui Zhang, Xingying Guo, Peng Wu, Zhibo Zhang, Xiangyan Huang. Serological identification and molecular characterization of B (A) 02 subtype in patients and blood donors from Eastern China[J]. Blood&Genomics, 2017, 1(1): 55-59. DOI: 10.46701/APJBG.20170117016
    [10]Meng Gao, Rong Huang, Hao Tang, Yunfeng Fu, Fengxia Liu, Rong Gui. A Chinese perspective on factors and molecular mechanisms that influence the curative effects of platelet transfusion[J]. Blood&Genomics, 2017, 1(1): 11-16. DOI: 10.46701/APJBG.20170116014

Catalog

    Article Metrics

    Article views (1336) PDF downloads (1033) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return